Tag: Human Papillomavirus (HPV)
Concomitant Administration of 9vHPV With MCV4/Tdap Feasible
Noninferior to intermittent administration of vaccines for 11- to 15-year olds
CDC: Too Few U.S. Adolescents Getting HPV Vaccination
4 out of 10 girls, 6 out of 10 boys haven't started series
HPV16 DNA in Oral Rinses at Oropharyngeal Cancer Diagnosis
But rarely seen after treatment; correlations for persistent HPV16 DNA with worse survival
CMS Finalizes Decision to Cover HPV Testing for Cervical Cancer
AAFP encouraged CMS to consider coverage and follow through on proposal
Few U.S. States Mandate Human Papillomavirus Vaccine
Immunization protects against sexually transmitted disease, certain cancers, health experts say
One Vaccine Dose May Adequately Protect Against HPV
Two large international trials suggest single immunization may be as good as two or three
HPV Vaccination of Females Has Some Indirect Benefit for Males
Strongest effect on penile cancer; smallest effect on anal cancer
Early Benefits for Quadrivalent HPV Vaccine in Canadian Teens
Reduced incidence of dysplasia and anogenital warts among girls vaccinated in grades 8 to 9
HLA Expression Tied to Penile Cancer Outcomes
HLA-A is an independent predictor of poor survival in HPV-negative patients
HPV4 Vaccine Cost-Effective for OPC Prevention in Teen Boys
Quadrivalent vaccine appears cost-effective among 12-year-old boys in Canada
